Florian D. Vogl

2.9k total citations
52 papers, 940 citations indexed

About

Florian D. Vogl is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Florian D. Vogl has authored 52 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Florian D. Vogl's work include Cancer Genomics and Diagnostics (9 papers), Microtubule and mitosis dynamics (6 papers) and Cancer-related Molecular Pathways (6 papers). Florian D. Vogl is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Microtubule and mitosis dynamics (6 papers) and Cancer-related Molecular Pathways (6 papers). Florian D. Vogl collaborates with scholars based in United States, Germany and Italy. Florian D. Vogl's co-authors include R. Kreienberg, Ingo B. Runnebaum, Klaus Pantel, Stephan Braun, Wolfgang Janni, William R. Taylor, Tanja Fehm, Marit Synnestvedt, Erich Solomayer and Brigitte Rack and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Florian D. Vogl

51 papers receiving 910 citations

Peers

Countries citing papers authored by Florian D. Vogl

Since Specialization

Citations

This map shows the geographic impact of Florian D. Vogl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian D. Vogl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian D. Vogl more than expected).

Fields of papers citing papers by Florian D. Vogl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian D. Vogl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian D. Vogl. The network helps show where Florian D. Vogl may publish in the future.

Co-authorship network of co-authors of Florian D. Vogl

This figure shows the co-authorship network connecting the top 25 collaborators of Florian D. Vogl. A scholar is included among the top collaborators of Florian D. Vogl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian D. Vogl. Florian D. Vogl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA35 Primary results from TACTI-003: A randomized phase IIb trial comparing eftilagimod alpha (soluble LAG-3) plus pembrolizumab versus pembrolizumab alone in first-line recurrent or metastatic head and neck squamous cell carcinoma with CPS ≥1 2024 ·Annals of Oncology ·(unknown), Robert L. Metcalf, (unknown), Simon Laban, (unknown), (unknown), (unknown), (unknown), Sebastian M. Dieter, (unknown), Stefan Kasper‐Virchow, (unknown), (unknown), Florian D. Vogl, (unknown), Frédéric Triebel	1
2	VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study 2024 ·Annals of Oncology ·Robert L. Metcalf, Simon Laban, (unknown), T-E. Ciuleanu, (unknown), (unknown), Sebastian M. Dieter, Alain Bols, Martin Förster, (unknown), (unknown), Florian D. Vogl, (unknown), Frédéric Triebel	1
3	Personalised pose estimation from single-plane moving fluoroscope images using deep convolutional neural networks 2022 ·PLoS ONE ·Florian D. Vogl, Pascal Schütz, Barbara Postolka, Renate List, William R. Taylor	2
4	Differentiation between mechanically loose and fixed press-fit implants using quantitative acoustics and load self-referencing: A phantom study on shoulder prostheses in polyurethane foam 2020 ·PLoS ONE ·Florian D. Vogl, (unknown), Philippe Favre, William R. Taylor, (unknown)	1
5	562P Target engagement and clinical safety of CB-103, a first-in-class small molecule inhibitor of the NOTCH transcription complex 2020 ·Annals of Oncology ·(unknown), José Manuel Pérez García, Javier Cortés, Elena Miranda, Ilaria Colombo, Elena Garralda, Dagmar Hess, Paolo Nucíforo, Ana Vivancos, (unknown), Oliver Schönborn‐Kellenberger, Karin Jorga, (unknown), (unknown), Rajwinder Lehal, Maximilien Murone, Michael Bauer, Pavel Pisa, Florian D. Vogl, Anastasios Stathis	1
6	Can low-frequency guided waves at the tibia paired with machine learning differentiate between healthy and osteopenic/osteoporotic subjects? A pilot study 2018 ·Ultrasonics ·Florian D. Vogl, Bernd Friesenbichler, (unknown), Inès A. Kramers‐de Quervain, William R. Taylor	24
7	Towards assessing cortical bone porosity using low-frequency quantitative acoustics: A phantom-based study 2017 ·PLoS ONE ·Florian D. Vogl, (unknown), (unknown), William R. Taylor	5
8	Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population 2017 ·Supportive Care in Cancer ·Aniket A. Kawatkar, Albert J. Farias, Chun Chao, Wansu Chen, Richard Barron, Florian D. Vogl, David Chandler	26
9	Reliability of Phase Velocity Measurements of Flexural Acoustic Waves in the Human Tibia In-Vivo 2016 ·PLoS ONE ·Florian D. Vogl, (unknown), Hans Gerber, William R. Taylor	5
10	Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim 2015 ·Supportive Care in Cancer ·Hairong Xu, Qi Gong, Florian D. Vogl, Maureen Reiner, John H. Page	14
11	The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer—Further observations from the IMPACT solid study 2015 ·The Breast ·Johanna Mäenpää, Ioannis Varthalitis, Frans Erdkamp, Andreas Trojan, Krzysztof Krzemieniecki, Henrik Lindman, (unknown), Florian D. Vogl, Shailendra Verma	8
12	Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis 2011 ·Clinical Cancer Research ·Wolfgang Janni, Florian D. Vogl, Gro Wiedswang, Marit Synnestvedt, Tanja Fehm, Julia Jückstöck, Elin Borgen, Brigitte Rack, Stephan Braun, Harald Sommer, Erich Solomayer, Klaus Pantel, Jahn M. Nesland, Klaus Friese, Bjørn Naume	192
13	Adapted Finnish Migraine‐Specific Questionnaire for family studies (FMSQ_FS): a validation study in two languages 2008 ·European Journal of Neurology ·Maurizio Facheris, Florian D. Vogl, (unknown), (unknown), Cristian Pattaro, (unknown), Peter P. Pramstaller	3
14	The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives 2007 ·BMC Medical Genetics ·Cristian Pattaro, Fabio Marroni, (unknown), Deborah Mascalzoni, Irene Pichler, Cláudia B. Volpato, (unknown), Alessandro De Grandi, (unknown), (unknown), Christian Fuchsberger, Martin Gögele, (unknown), (unknown), Стефан Стефанов, Florian D. Vogl, Christian J. Wiedermann, Thomas Meitinger, Peter P. Pramstaller	42
15	Disseminated tumor cells: Are they ready for clinical use? 2007 ·The Breast ·Stephan Braun, Florian D. Vogl, (unknown), Daniel Egle, (unknown), (unknown), Christian Marth	6
16	Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred 2006 ·Familial Cancer ·Florian D. Vogl, (unknown), Linda Steele, Susan L. Neuhausen, David E. Goldgar	3
17	Population Isolates in South Tyrol and Their Value for Genetic Dissection of Complex Diseases 2006 ·Annals of Human Genetics ·Fabio Marroni, Irene Pichler, Alessandro De Grandi, Cláudia B. Volpato, Florian D. Vogl, (unknown), Joan E. Bailey‐Wilson, Peter P. Pramstaller	13
18	Prospective Evaluation of Factors Influencing Success Rates of Sentinel Node Biopsy in 814 Breast Cancer Patients 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Holger Schirrmeister, Jörg Kotzerke, Florian D. Vogl, Andreas K. Buck, Norbert Czech, K Koretz, (unknown), R. Kreienberg, Thorsten Kühn	18
19	Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial 2003 ·European Journal of Surgical Oncology ·Thorsten Kuehn, Florian D. Vogl, G Helms, (unknown), Holger Schirrmeister, (unknown), K Koretz, R. Kreienberg	52
20	p53 Autoantibodies in Patients with Primary Ovarian Cancer Are Associated with Higher Age, Advanced Stage and a Higher Proportion of p53-Positive Tumor Cells 1999 ·Oncology ·Florian D. Vogl, Elmar Stickeler, Maria Weyermann, (unknown), H.‐J. Grill, Gian Luca Negri, R. Kreienberg, Ingo B. Runnebaum	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact